RBC Capital analyst Kendall Au has reiterated a 'Sector Perform' rating on Inspire Medical Systems (INSP) and increased its price target from $60 to $75. This indicates a moderately positive outlook from the analyst, suggesting potential upside for the stock but not a strong buy recommendation.
RBC Capital analyst Kendall Au has maintained a 'Sector Perform' rating on Inspire Medical Systems (INSP) while raising the price target from $60 to $75. This action signals a moderately positive sentiment from the analyst, suggesting that while the stock is expected to perform in line with its sector, there is an increased valuation expectation. For traders, this could imply a short-term opportunity for price appreciation towards the new target, but it's not a strong catalyst for a significant upward re-rating. The 'Sector Perform' rating indicates that the analyst believes the stock's growth prospects are already largely priced in, despite the higher target.